12:20 PM EDT, 10/25/2024 (MT Newswires) -- ImmunityBio ( IBRX ) shares were rallying 40% Friday after the company said Thursday it dosed the first patients in a phase 1 trial that will assess its CAR-NK cellular therapy as a potential treatment for non-Hodgkin's lymphoma. The Quilt 106 trial will initially use CD19-targeted high-affinity natural killer cells alone and, if...

MILAN, Oct 25 (Reuters) - Italian energy group Eni expects 2.5 billion euros ($2.7 billion) in net proceeds from additional disposals that will be completed next year, Chief Transition & Financial Officer Francesco Gattei said on Friday. The group announced on Thursday that U.S. investment group KKR would buy 25% of its biofuel unit Enilive for 2.9 billion euros as...

WASHINGTON (Reuters) - A trade conflict between the United States and the European Union would not see any winner but only losers, German Finance Minister Christian Lindner told Reuters in an interview. Lindner said he was following the toss-up U.S. presidential race between Republican Donald Trump and Democrat Kamala Harris, and saw the risk of tariffs in the next U.S....

(Reuters) -Septerna's shares rose about 31% in their market debut on Friday, giving the Goldman Sachs ( GS )-backed biotech firm a valuation of $970 million. The company's shares opened at $23.5 in their Nasdaq debut, compared with the IPO price of $18. Septerna upsized its offering twice on Thursday to sell 16 million shares, to raise $288 million. Biotech...